Global Gene Therapy Cell Culture Media Market By Type (Serum Containing Media, Serum Free Media, Stem Cell Media), By Application (Biotecnology & Pharmacuticals, Academics, Research), By Region, And S...
Report Id: 44150 | Published Date: May 2024 | No. of Pages: 5 | Base Year for Estimate: May 2024 | Format:
Market Overview:
The global gene therapy cell culture media market is experiencing rapid growth due to the increasing adoption of gene therapy for the treatment of various genetic disorders, cancers, and infectious diseases. Gene therapies are used to treat a wide variety of illnesses. Instead of just treating the symptoms, they take a radical approach to treating the underlying cause of the diseases. Additionally, a wide range of previously untreated illnesses, include haematological, ocular, and several other cancers. There also has been an increase in enhanced protein-free media, for the development and growth of viral vectors. Since many gene therapy companies see this as an opportunity to find a vaccine, the demand for gene and cell therapy has increased in clinical trials for the development of the COVID-19 vaccine.
Gene Therapy Cell Culture Media Market was valued at USD 6 billion in 2023 and is projected to reach USD 13.1 billion by 2028, growing at a CAGR of 16.1% from 2024-2028. The major factors that contribute toward the expansion of the Gene Therapy Cell Culture Media Market include a rise in R&D investments and growth in awareness regarding gene therapy
Premium Insights:
-The rising prevalence of genetic disorders and the growing demand for personalized medicine are driving the adoption of gene therapy, thereby fueling the demand for cell culture media.
-Technological advancements in cell culture media formulations, such as serum-free and chemically defined media, are enhancing cell growth kinetics, productivity, and product consistency.
-The emergence of novel gene editing technologies, such as CRISPR-Cas9, is expanding the scope of gene therapy applications and driving the need for specialized cell culture media formulations to support efficient gene delivery and expression.
Global Gene Therapy Cell Culture Media Market Dynamics:
Drivers: FBS, rising investments, advancing bioprocessing technologies, rising regulatory approvals for gene therapy products
-Fetal Bovine Serum (FBS) which is the most widely used and preferred media supplement for cell culture, consists of numerous growth factors and hormones that can help with cell growth. This has played a major role in the shift towards the development and adoption of serum-free cell culture processes.
- Increasing Investments in Gene Therapy Research by biopharmaceutical companies, academic institutions, and government organizations in gene therapy research and development are driving the demand for cell culture media for preclinical and clinical studies.
- Continuous advancements in bioprocessing technologies, including cell line engineering, vector production, and purification methods, are driving the need for customized cell culture media formulations tailored to specific gene therapy applications.
- The growing number of regulatory approvals for gene therapy products, coupled with favourable reimbursement policies, is boosting market growth by encouraging the commercialization and adoption of gene therapy treatments.
Restraints: High maintenance and costs, underdeveloped facilities in developing countries pose restraints to growth
-Extensive research is involved in cell biology for the development of new therapies, such as gene therapies and stem cells. The media reagents as well as other products associated with this research are required to be of high quality to obtain accurate results. The maintenance of the above factors in compliance with guidelines set up by regulatory authorities along with the high research cost in cell biology determine the market growth significantly
- underdeveloped infrastructure facilities and low healthcare expenditure in developing countries restrict the use of advanced equipment and consumables. The usage of advanced media and kits is way more expensive as compared to conventional ones.
Opportunities: Increasing focus on genetic diseases, the prevalence of new cancer cases, and rising interest in gene therapy.
-The increasing focus on rare genetic diseases, oncology, and infectious diseases presents significant opportunities for market players to develop innovative cell culture media formulations optimized for the production of gene therapy vectors and genetically modified cells
- The growth in the prevalence of cancer has resulted in a need to conduct extensive research for diagnosis and treatment which in turn provides growth opportunities for cell culture technologies and cell culture media products
- The rising incidence of communicable diseases like influenza, flu and others is among the major factors driving the demand for diagnostics across the world, providing potential growth opportunities for players operating in the market.
-The expanding pipeline of gene therapy candidates and the adoption of advanced manufacturing technologies, such as viral vector platforms and gene editing tools, offer avenues for market expansion and diversification.
Market by Gene Therapy Cell Culture Media Type Insights:
Based on Type the market is segmented into serum-containing media, serum-free media, stem cell media, chemically defined media, and others. As per the media type, the chemical-defined media is the major contributor in terms of revenue and is projected to grow further. This can be attributed to the increased funding for cell-based research and repeated purchases of consumables.
Market By End Use Insights:
Based on End-users, the market is segmented into the biotechnology and pharmaceutical industry, research Laboratories, academic institutes, and others. Biopharmaceutical companies represent the largest end-user segment, driven by their extensive investments in gene therapy pipelines, manufacturing infrastructure, and commercialization efforts.
Market by Region Insights:
Based on regional coverage, the global gene therapy cell culture media market is segmented into North America, Europe, and Asia Pacific. Asia-Pacific is a rapidly growing market advantageous for key industry players. North America dominates the gene therapy cell culture media market attributed to the presence of key industry players, robust research infrastructure, and supportive regulatory frameworks fostering innovation and commercialization.
Competitive Scenario :
Major players operating in this market are Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Takara Holdings Inc., Danaher Corporation, Novartis International AG, Sartorius AG, HiMedia Laboratories Pvt., Ltd., Lonza Group Ltd., and Bio-Techne Corporation.
Scope of Work- Global Gene Therapy Cell Culture Media Market
Key Market Developments:
June 2023- Thermo Fisher launched the Tumoroid Culture medium to accelerate the development of novel cancer therapies.
November 2023- Lonza Group AG announced the expansion of its cell culture media manufacturing facility in the United States to meet the growing demand for gene therapy manufacturing solutions.
March 2022- FUJIFILM Irvine Scientific launched the BalanCD CHO Media platform portfolio for bioprocessing
January 2024- Merck KGaA launched its EX-CELL Advanced HD Cell Culture Media, a chemically defined, animal component-free medium designed for the scalable production of viral vectors and gene-modified cells.
Frequently Asked Questions (FAQs)
What are the key applications of gene therapy cell culture media?
Ans. Gene therapy cell culture media are used for the production of viral vectors, genetically modified cells, and gene-edited cell lines used in gene therapy research, preclinical studies, and clinical trials.
What factors contribute to the regional growth disparities in the gene therapy cell culture media market?
Ans. Several factors contribute to the growth such as research and development investments, healthcare infrastructure, FBS, and advancement in bioprocessing technologies among others.
What is the projected market revenue value of the global cell culture media market?
Ans. The global gene therapy cell culture media market is valued at a total revenue of USD 12.9 billion by 2028
What are gene therapy culture media cells used for?
Ans. Gene therapy culture media cell is used for settings for proliferation, maintenance, growth and storage of microorganisms and other cell types such as stem cells and other cell lines
Speak with an analyst to get exclusive insights tailored to your needs